The NIH RECOVER Long-COVID Clinical Trials are Set to Fail: Here’s What Should be Trialed Instead

The NIH RECOVER Long-COVID Clinical Trials are Set to Fail: Here’s What Should be Trialed Instead

by | May 10, 2024 | Abilify, Antivirals, Drugs, Homepage, Ivabradine, IVIG, long COVID, Low Dose Naltrexone, Paxlovid, RECOVER Initiative, Stimulants

Check out Geoff’s narration The GIST The Blog   Thanks to John Bolecek for putting together this thought-provoking blog. A former Statewide Bicycle and Pedestrian Coordinator at the Virginia Department of Transportation, John was in great shape before he...

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest